Zika virus: NIH begins testing of investigational inactive Zika vaccine in humans : miamiherald

as declared in miamiherald

Zika virus: NIH begins testing of investigational inactive Zika vaccine in humans

Zika virus: NIH begins testing of investigational inactive Zika vaccine in humans

Drug combo shuts down a type of lung cancer, researchers findHuman trials begin for Army-developed Zika purified inactivated virus (ZPIV) vaccineIncrease in Parkinson's disease over 30 years, shows Mayo Clinic studyUM holds forum on ZikaWhat is a virtual colonoscopy?


by the same token on nih

Testing of investigational inactivated Zika vaccine in humans begins

Testing of investigational inactivated Zika vaccine in humans begins

Testing of investigational inactivated Zika vaccine in humans beginsFirst of five planned clinical trials to test ZPIV vaccine.The first of five early stage clinical trials to test the safety and ability of an investigational Zika vaccine candidate called the Zika Purified Inactivated Virus (ZPIV) vaccine to generate an immune system response has begun at the Walter Reed Army Institute of Research (WRAIR) Clinical Trial Center in Silver Spring, Maryland.Scientists with WRAIR, part of the U.S. Department of Defense (DoD), developed the vaccine.


coupled with latimes

Experimental Zika vaccine looks promising in animal tests

Experimental Zika vaccine looks promising in animal tests

An experimental vaccine has been shown to provide protection against the Zika virus in mice, and to mobilize an immune response against Zika in monkeys.The genetically engineered vaccine candidate includes genes that teach the immune system to recognize Zika by showing it several of the virus' surface proteins.Scientists are scrambling to find ways to protect large populations against Zika, a member of the flavivirus family that is the cause of severe brain abnormalities in babies born to women who were infected during their pregnancies.

Zika virus: NIH begins testing of investigational inactive Zika vaccine in humans